LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2021 Results - Earnings Call Transcript

Ligand Pharmaceuticals Incorporated (LGND) Q4 2021 Earnings Conference Call February 17, 2022 04:30 PM ET Company Participants Simon Latimer - Head of Investor Relations John Higgins - Chief Executive Officer Matt Korenberg - Chief Financial Officer Matt Foehr - Chief Operating Officer Conference Call Participants Joe Pantginis - H.C. Wainwright Larry Solow - CJS Securities Matt Hewitt - Craig-Hallum Jacob Johnson - Stephens Scott Henry - ROTH Capital Presentation Operator Good day and thank you for standing by and welcome to the Ligand Pharmaceuticals Q4 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that this call is being recorded. [Operator Instructions] I would now like to hand the conference over to your host today, Simon Latimer, Head of Investor Relations. You may begin. Simon Latimer Thank you, Justin. Welcome to Ligand's

For further details see:

Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2021 Results - Earnings Call Transcript